Kidney involvement in systemic lupus erythematosus (SLE), generally termed lupus
nephritis, is a major contributor to SLE-associated morbidity and mortality. Up to 50% of SLE
patients will have clinically evident kidney disease at presentation, and, during follow-up,
kidney involvement occurs in up to 75% of patients, with an even greater representation
among children and young adults. 1 Lupus nephritis has been shown to impact clinical
outcomes in SLE both directly via target organ damage and indirectly through complications …